For Research Purposes Only — Not for Human Consumption
Semaglutide Oral Capsules 3mg x30
About this compound
Semaglutide oral capsules, 3mg per capsule, 30-count bottle. Oral GLP-1 receptor agonist formulation for metabolic disease research — parallels the clinical oral semaglutide platform. Preclinical models study GLP-1 receptor engagement via intestinal absorption, appetite suppression, and glucose homeostasis endpoints. For laboratory research only.
Minimum 2 qty required ($178.00 total)
Accepted Payment Methods
This product is intended strictly for laboratory and in-vitro research. It has not been evaluated by the FDA and is not approved for human consumption, therapeutic use, or veterinary application. Always consult primary peer-reviewed literature and a qualified professional before drawing conclusions about any compound.
Capsules
